🔎 Trials Near Me

Home › Myelodysplastic Syndromes

Myelodysplastic Syndromes clinical trials recruiting in the U.S.

158 studies for Myelodysplastic Syndromes are recruiting participants at sites across the United States.

Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.

Cities with the most studies

By state

Recently updated studies

Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders

RecruitingObservational study
1 Day – 99 Years · All sexes · Updated Nov 13, 2026 · NCT07683104

Allogeneic iNKT Cell Therapy (agenT-797) After SCT

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07758218

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT01311258

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT04986657

HPC Offered for PRESERVE Expansion

RecruitingObservational study
Ages 12 to 80 · All sexes · Updated Nov 6, 2026 · NCT07145411

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT05308264

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT05969860

Personalized NK Cell Therapy in CBT

RecruitingPhase 2
Ages 15 to 80 · All sexes · Updated Nov 2, 2026 · NCT02727803

Mosaic Trial for Stem Cell Transplant Recipients

Recruiting
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06960993

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 29, 2026 · NCT06265584

Study of REM-422 in Patients With AML or Higher Risk MDS

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06297941

Prophylactic DLI-X for Leukemia Relapse After HCT

RecruitingPhase 1
Up to age 65 · All sexes · Updated Oct 29, 2026 · NCT07254793

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT02333604

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.